Results 71 to 80 of about 96,164 (192)

The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis [PDF]

, 2014
Su Jin Lee, Jae Do Yoo, Soo Young Choi, Oh‐Shin Kwon   +3 more
openalex   +1 more source

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma

Medicina
Introduction: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) stems from disrupted lipid metabolism in the liver, often linked to obesity, type 2 diabetes, and dyslipidemia.
Melchor Alpízar Salazar, Samantha Estefanía Olguín Reyes, Andrea Medina Estévez, Julieta Alejandra Saturno Lobos, Jesús Manuel De Aldecoa Castillo, Juan Carlos Carrera Aguas, Samary Alaniz Monreal, José Antonio Navarro Rodríguez, Dulce María Fernanda Alpízar Sánchez   +8 more
doaj   +1 more source

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study [PDF]

, 2020
Philip N. Newsome, M. Sasso, Jonathan J Deeks, Angelo H. Paredes, Jérôme Boursier, Wah‐Kheong Chan, Yusuf Yılmaz, Sébastien Czernichow, Ming‐Hua Zheng, Vincent Wai‐Sun Wong, Michael Allison, Emmanuel Tsochatzis, Quentin M. Anstee, David Sheridan, Peter Eddowes, Indra Neil Guha, Jeremy Cobbold, Valérie Paradis, Pierre Bédossa, Véronique Miette, Céline Fournier‐Poizat, Laurent Sandrin, Stephen Harrison   +22 more
openalex   +1 more source

Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

, 2023
Mazen Noureddin
openalex  

Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis [PDF]

, 2020
Simona Panunzi, Sabina Maltese, Ornella Verrastro, Luca L’Abbate, Andrea De Gaetano, Maurizio Pompili, Esmeralda Capristo, Stefan R. Bornstein, Geltrude Mingrone   +8 more
openalex   +1 more source

Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis [PDF]

, 2020
Anna Kakehashi, Shugo Suzuki, Naomi Ishii, Takahiro Okuno, Yuko Kuwae, Masaki Fujioka, Min Gi, В. Е. Стефанов, Hideki Wanibuchi   +8 more
openalex   +1 more source

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

, 2021
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, Dominik Pfister, Michal Safran, Baoguo Li, Amir Giladi, Diego Adhemar Jaitin, Oren Barboy, Merav Cohen, Ido Yofe, Chamutal Gur, Shir Shlomi-Loubaton, Sandrine Henri, Suhail Yousuf, Mengjie Qiu, Shing Kam, Hila Hermon, Eylon Lahat, Gil Ben Yakov, Oranit Cohen‐Ezra, Yana Davidov, Mariya Likhter, David Goitein, Susanne Roth, Achim Weber, Bernard Malissen, Assaf Weiner, Ziv Ben‐Ari, Mathias Heikenwälder, Eran Elinav, Ido Amit   +31 more
openalex   +2 more sources

Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients [PDF]

Sarah Flynn, Varun Saxena, Danielle Brandman   +2 more
openalex   +1 more source

249 Engineered mesenchymal stem cell extracellular vesicles loaded with miRNA-34a modulate stemness biomarkers in the CD133+/CD90+ liver cancer stem cell subpopulation linked to nonalcoholic steatohepatitis. [PDF]

Amira Fyala, Ahmed Sultan
openalex   +1 more source

Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease. [PDF]

World J Gastroenterol
Heymann G, Rahman S, Kats D, Banini BA, Gaddam S, Aslanian E, Boateng S, Israel G, Muniraj T.   +8 more
europepmc   +1 more source